Table of Contents Year 2022Research Paper
Conference papers
4:- Abstracts of the Papers Presented in the International Symposium on Safety Assessment under Materiovigilance and Pharmacovigilance Programs, on 20 May, 2022 organized by
-Delhi Pharmaceuticals Sciences & Research University, Govt of NCT of Delhi, INDIA,
-Indian Pharmacopoeia Commission, MoHFW, Govt of India, INDIA,
-University of Valladolid, Valladolid, SPAIN,
-University College Sedaya International, KL, MALAYSIA
4.1. Overview ofMateriovigilance program of Govt. of INDIA. V. Kalaiselvan. Senior Principal Scientific Officer.
4.2. Systematic review and meta-analysis of adverseeffects associated with monoclonal antibodies used in different inflammatoryconditions and breast cancer. Mathur R, Raina P, Sweety, Kumar D, Goyal RK
4.3. Risks and Benefit Analysis of Medications. Kumar Anoop
4.4. Integrating
Pharmacovigilance and Materiovigilance programs for enhanced sustainability. Raghuvanshi Rajeev Singh
4.5. The toxicity of
compounds used in intraocular surgery and the failures of the European security
system. The MDR as a response from the European Union. J.C. Pastor
4.6. Suitability of ISO standards for medical
device toxicity measurement. Girish K. Srivastava. Distinguished Senior Scientist.
4.7. Ethambutoloptic neuropathy: Concerns and solutions. Saxena Rohit MD, PhD
4.8. Assessment of
Drug-Induced Ocular toxicity in animal models using Electroretinogram and
Gyro-Dot-OMR model. Nath Madhu & Prasad Hanuman Sharma
4.9. OrthopaedicImplant Failure –An Overview. Sural Sumit. Director Professor.
5.0. Ethambutol induced ocular toxicity. Goel A, Saxena R, Kalaiselvan V, Goyal RK, Mohan A, Mathur R
5.1. Safety study of Intrauterine Contraceptive Devicesconsidering Asian population. Aishwarya G, Kalaiselvan V, Goyal RK, Mathur R
5.2. Systematic review offailure of primary total hip arthroplasty and meta-analysis of safety profileof two different material of acetabular cup. Sharma A, Sural S, Kumar AA, Kalaiselvan V,Mathur R
5.3. Pharmacovigilance Study Among Covid-19 Subjects
And Subjects Vaccinated Against Covid-19 At National Heart Institute. Chand Neha, Mathur Rajani,
Dwivedi Shridhar
5.4. Association of anti-diabetic medications with DILI:
A Disproportionality analysis. Javed
Faiza and Kumar Anoop
Editorial
5:- Disadvantages of iPS technology. Girish K. Srivastava
-----------------------------------------------------------------------------------
Tentative number of articles: 5
Tentative date of issue: 31/12/2022